Effects of the FGF receptor‐1 inhibitor, infigratinib, with or without sildenafil, in experimental pulmonary arterial hypertension - Concepedia

Concepedia

Publication | Open Access

Effects of the FGF receptor‐1 inhibitor, infigratinib, with or without sildenafil, in experimental pulmonary arterial hypertension

DOI Full Paper Access

16

Citations

30

References

2019

Year

Nathane Santanna Felix, L. Mendonça, Cássia L. Braga, Jaqueline da Silva, Cynthia S. Samary, Juliana Borges Vieira, Fernanda Ferreira Cruz, Nazareth N. Rocha, Gisele Zapata‐Sudo, Patrícia R. M. Rocco,

British Journal of Pharmacology

Abstract

In this model of monocrotaline-induced PAH, the combination of the new inhibitor of FGF receptor-1, infigratinib, and sildenafil effectively improved haemodynamics and decreased vascular remodelling.

References

	Year	Citations

Page 1